SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Teladoc Health shares are trading lower after the company reported worse-than-expected Q2 EPS results. The company also issued Q3 and FY20 EPS guidance below analyst estimates. NOTE: Shares have reversed since then.

Benzinga · -